These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34717640)

  • 1. Dysregulation of the miR-30a/BiP axis by cigarette smoking accelerates oral cancer progression.
    Chien CY; Chen YC; Lee CH; Wu JR; Huang TW; Huang RY; Cheng WC; Hsieh AC; Shieh YS
    Cancer Cell Int; 2021 Oct; 21(1):578. PubMed ID: 34717640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP-Dependent BiP Induction Is Involved in Nicotine-Mediated Oral Cancer Malignancy.
    Chien CY; Chen YC; Hsu CC; Chou YT; Shiah SG; Liu SY; Hsieh AC; Yen CY; Lee CH; Shieh YS
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer.
    Shiah SG; Hsiao JR; Chang HJ; Hsu YM; Wu GH; Peng HY; Chou ST; Kuo CC; Chang JY
    J Biomed Sci; 2020 Apr; 27(1):46. PubMed ID: 32238162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
    BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma.
    Kawahara K; Nagata M; Yoshida R; Hirosue A; Tanaka T; Matsuoka Y; Arita H; Nakashima H; Sakata J; Yamana K; Kawaguchi S; Gohara S; Nagao Y; Hirayama M; Takahashi N; Hirayama M; Nakayama H
    Biochem Biophys Rep; 2021 Dec; 28():101114. PubMed ID: 34589618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells.
    Yen YC; Shiah SG; Chu HC; Hsu YM; Hsiao JR; Chang JY; Hung WC; Liao CT; Cheng AJ; Lu YC; Chen YW
    Mol Cancer; 2014 Jan; 13():6. PubMed ID: 24410957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin Inhibits the Progression of Oral Squamous Cell Carcinoma
    Wang Y; Tao B; Li J; Mao X; He W; Chen Q
    Front Oncol; 2020; 10():543591. PubMed ID: 33344223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA BLACAT1 regulates the viability, migration and invasion of oral squamous cell carcinoma cells by targeting miR-142-5p.
    Dai D; Feng XD; Zhu WQ; Bao YN
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10313-10323. PubMed ID: 31841186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis.
    Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):425-433. PubMed ID: 34409798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KCNQ1OT1 promotes migration and inhibits apoptosis by modulating miR-185-5p/Rab14 axis in oral squamous cell carcinoma.
    Bao Q; Liao X; Li R; Ding N
    Dev Growth Differ; 2019 Dec; 61(9):466-474. PubMed ID: 31755091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoke condensate promotes pro-tumourigenic stromal-epithelial interactions by suppressing miR-145.
    Pal A; Melling G; Hinsley EE; Kabir TD; Colley HE; Murdoch C; Lambert DW
    J Oral Pathol Med; 2013 Apr; 42(4):309-14. PubMed ID: 23173553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
    Wang XC; Ma Y; Meng PS; Han JL; Yu HY; Bi LJ
    Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
    Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
    Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
    Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
    Niu X; Yang B; Liu F; Fang Q
    Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 18. LncRNA SNHG20 enhances the progression of oral squamous cell carcinoma by regulating the miR-29a/DIXDC1/Wnt regulatory axis.
    Chen ZF; Wang Y; Sun LL; Ding SY; Jinag H
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5436-5445. PubMed ID: 32495922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-769-5p inhibits cancer progression in oral squamous cell carcinoma by directly targeting JAK1/STAT3 pathway.
    Zhou Y; Xu XM; Feng Y
    Neoplasma; 2020 May; 67(3):528-536. PubMed ID: 32064884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Non-Coding RNA LINC01929 Accelerates Progression of Oral Squamous Cell Carcinoma by Targeting the miR-137-3p/FOXC1 Axis.
    Che H; Che Y; Zhang Z; Lu Q
    Front Oncol; 2021; 11():657876. PubMed ID: 33968763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.